Skip to main content
UniHealth

Doctor search

Anurag Shrivastava, MD

Ophthalmology · Bronx

NPI 1760518823

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Montefiore Medical Center · 2,809 clinicians in this group

Looking this up.

Hospitals listed: Montefiore Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shrivastava’s office to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Montefiore Medical CenterBronx, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montefiore Medical Center, which runs 8 hospitalsHome of Montefiore Einstein Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 2 of 5 · 65% would definitely recommend it
    Overall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.23 (1.01 to 1.45), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.96 (4.4 to 7.52) · 3,522 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 0.95 (0.64 to 1.26) · 17,685 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.679, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.584, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.283, Oct 2024 – Sep 2025
See every measure and the patient survey for Montefiore Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 7 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Montefiore Medical Center
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.23 (1.01 to 1.45)WorseJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.96 (4.4 to 7.52) · 3,522 casesWorseJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.64 to 1.26) · 17,685 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.679BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.584BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.283BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.7 (0 to 1.48) · 3,839 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths173.71 (144.1 to 203.32) · 293 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 71 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7 · 228 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.9 · 235 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths5.2 · 726 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths9.2 · 878 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths7.5 · 1,164 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.4 · 13,803 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.1 (0 to 0.26) · 18,946 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.05 to 0.36) · 20,155 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.42 (0.03 to 2.82) · 1,159 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.47 (1.29 to 3.65) · 3,435 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.77 (5.48 to 16.06) · 1,120 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.47 (3.29 to 9.65) · 1,192 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.92 (0.57 to 3.28) · 744 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths2.8 · 1,424 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.812No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections1.336No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.058No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits17.8 · 722 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.8 · 2,620 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits22 · 255 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-18 · 840 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-6.4 · 886 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 2,180 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.1 (2.8 to 5.7) · 356 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.2 (10.5 to 16.3) · 356 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 1,427 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.9 · 170 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits22.3 · 973 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.3 (9.3 to 16.2) · 803 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.6 to 1.1) · 627 casesNo differentJan 2024 – Dec 2024

What patients said (4,904 patients answered, 11% of those asked)

Patient survey stars by topic at Montefiore Medical Center
Cleanliness3
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Montefiore Medical Center
Room was "always" clean68%
Nurses "always" communicated well75%
Doctors "always" communicated well78%
Staff "always" explained59%
Yes, staff "did" give patients this information81%
Yes, staff "did" give patients information about help after discharge79%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully76%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital65%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms82%

Original Medicare doctor bills

$25,114

Medicare paid this office $25,114 for 157 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Established patient complete exam of visual system81$11,620$106
Short return visit (20+ min)33$2,420$71
Return visit (30+ min)16$1,638$96
Imaging of optic nerve40$1,316$31
Exam of visual field with extended testing18$811$45
See all 6 services
Every Original Medicare service billed
Established patient complete exam of visual system81$11,620$106
Short return visit (20+ min)33$2,420$71
Return visit (30+ min)16$1,638$96
Imaging of optic nerve40$1,316$31
Exam of visual field with extended testing18$811$45
Exam of the internal drainage system of eye13$266$19

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

157 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 10% · Women 64% · Also on Medicaid 33% · Health risk score 1.23. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 51% · Chronic kidney disease 29% · Coronary heart disease 18% · Cancer 15% · COPD 14% · Heart failure 13% · Depression 11% · Stroke 10% · Atrial fibrillation 9%.

The office billed $192,845, Medicare allowed $35,857 and paid $25,114; for 303 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024157303731.23$192,845$25,114
2023130262721.28$142,010$17,878
2022150262711.37$130,913$20,468
2021134271701.53$128,145$19,078
2020126244711.53$98,383$14,109
2019248577721.50$200,740$31,583
2018239479701.56$184,265$28,273
2017268524711.55$234,872$32,210
2016236436701.42$201,797$26,338
2015271490711.63$131,557$31,087
2014248419721.47$233,815$48,697
2013310689701.61$310,097$71,553

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Established patient complete exam of visual system76$8,966$96
Short return visit (20+ min)37$2,558$64
Imaging of optic nerve33$978$30
Exam of visual field with extended testing12$485$40
Exam of the internal drainage system of eye23$384$17

2022: 6 services

Original Medicare services billed in 2022
Established patient complete exam of visual system76$9,948$103
Short return visit (20+ min)32$2,757$81
New patient visit (30+ min)14$1,557$111
Exam of visual field with extended testing16$939$59
Imaging of optic nerve27$867$32
Exam of the internal drainage system of eye12$292$24

2021: 6 services

Original Medicare services billed in 2021
Established patient complete exam of visual system62$6,755$98
Return visit (30+ min)32$3,416$100
Short return visit (20+ min)28$2,232$77
Imaging of optic nerve39$1,175$29
Exam of visual field with extended testing12$734$61
Exam of the internal drainage system of eye22$519$23

2020: 6 services

Original Medicare services billed in 2020
Established patient complete exam of visual system60$6,180$90
Short return visit (20+ min)24$1,525$59
Established patient complete exam of visual system19$1,226$58
Imaging of optic nerve26$796$27
Exam of visual field with extended testing13$781$60
Exam of the internal drainage system of eye20$432$21

2019: 14 services

Original Medicare services billed in 2019
Established patient complete exam of visual system107$12,449$100
Established patient complete exam of visual system55$3,939$64
Short return visit (20+ min)43$3,084$57
Established patient problem focused exam of visual system30$1,616$46
Imaging of optic nerve48$1,561$31
Established patient problem focused exam of visual system17$1,224$72
Short return visit (20+ min)25$952$37
Exam of visual field with extended testing15$818$55
Exam of the internal drainage system of eye31$753$22
New patient visit (30+ min)11$731$66
Imaging of optic nerve26$417$16
Exam of visual field with extended testing12$273$23
Ultrasound scan of cornea to determine thickness23$220$10
Ultrasound scan of cornea to determine thickness12$74$6

2018: 10 services

Original Medicare services billed in 2018
Established patient complete exam of visual system99$11,103$93
Established patient complete exam of visual system58$4,010$62
Short return visit (20+ min)40$2,821$58
Short return visit (20+ min)33$1,281$37
Imaging of optic nerve34$1,159$33
Exam of visual field with extended testing16$787$49
Imaging of optic nerve26$404$15
Exam of visual field with extended testing12$223$19
Ultrasound scan of cornea to determine thickness17$217$13
Ultrasound scan of cornea to determine thickness11$90$8

2017: 11 services

Original Medicare services billed in 2017
Established patient complete exam of visual system103$12,736$104
Established patient complete exam of visual system72$5,312$62
Short return visit (20+ min)35$2,241$59
Imaging of optic nerve34$1,039$31
Short return visit (20+ min)23$1,020$38
Established patient problem focused exam of visual system22$959$44
Photography of the retina12$743$62
Exam of visual field with extended testing17$339$19
Imaging of optic nerve20$325$16
Photography of the retina16$293$18
Ultrasound scan of cornea to determine thickness20$239$12

2016: 14 services

Original Medicare services billed in 2016
Established patient complete exam of visual system52$6,138$106
Return visit (30+ min)52$4,580$80
Short return visit (20+ min)32$2,049$59
Return visit (30+ min)32$1,604$50
Established patient complete exam of visual system23$1,469$64
Short return visit (20+ min)28$1,188$40
New patient visit (30+ min)13$961$74
Photography of the retina13$961$74
Imaging of optic nerve25$871$33
Imaging of optic nerve17$372$20
Exam of the internal drainage system of eye13$289$22
Exam of the internal drainage system of eye13$186$14
Ultrasound scan of cornea to determine thickness14$173$12
Ultrasound scan of cornea to determine thickness14$72$5

2015: 10 services

Original Medicare services billed in 2015
Established patient complete exam of visual system99$11,236$97
Established patient complete exam of visual system58$3,804$62
Short return visit (20+ min)42$2,781$53
Exam of visual field with extended testing31$1,983$55
Return visit (30+ min)16$1,650$97
Imaging of optic nerve36$1,313$36
Exam of visual field with extended testing30$695$23
Short return visit (20+ min)16$596$37
Imaging of retina18$588$26
Imaging of optic nerve22$472$21

2014: 11 services

Original Medicare services billed in 2014
Complex removal of cataract with insertion of prosthetic lens13$11,136$742
Removal of cataract with insertion of prosthetic lens13$7,564$582
Established patient complete exam of visual system68$5,559$78
Established patient complete exam of visual system65$3,730$57
Measurement of corneal curvature and depth of eye50$2,658$53
Long return visit (40+ min)17$1,333$78
Short return visit (20+ min)21$1,029$47
Photography of the retina13$846$65
Short return visit (20+ min)22$691$30
Exam of visual field with extended testing20$490$25
Photography of the retina11$151$14

2013: 17 services

Original Medicare services billed in 2013
Removal of cataract with insertion of prosthetic lens15$10,181$599
Complex removal of cataract with insertion of prosthetic lens12$10,149$725
Established patient complete exam of visual system80$8,642$91
Short return visit (20+ min)66$5,264$61
Established patient complete exam of visual system67$4,796$62
Return visit (30+ min)31$2,935$92
Long return visit (40+ min)16$2,152$127
Measurement of corneal curvature and depth of eye32$1,696$46
Short return visit (20+ min)41$1,650$34
Return visit (30+ min)28$1,627$54
Photography of the retina26$1,430$55
New patient complete exam of visual system12$1,414$118
Exam of visual field with extended testing20$1,234$59
Long return visit (40+ min)14$1,166$83
Imaging of optic nerve26$912$35
Exam of visual field with extended testing27$599$21
Photography of the retina16$288$18

Medicaid work

$12,632 in 2024

Medicaid paid $12,632 for 225 billed services this clinician did in 2024, up to 25 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST201$11,596
Short return visit (20+ min)12$916
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve12$120
Medicaid work by year
2024225325$12,632
2023195227$12,296
2022186120$11,783
2021129225$9,961
202097118$4,923
2019309233$20,624
2018254325$22,882
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST169$9,917
Short return visit (20+ min)26$2,378

2022

Largest Medicaid services in 2022
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST186$11,783

2021

Largest Medicaid services in 2021
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST116$8,798
Short return visit (20+ min)13$1,162

2020

Largest Medicaid services in 2020
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST97$4,923

2019

Largest Medicaid services in 2019
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST255$17,935
Short return visit (20+ min)54$2,689

2018

Largest Medicaid services in 2018
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST225$21,185
Short return visit (20+ min)17$1,226
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve12$471

Drugs they prescribed that Part D paid

$300,663

Pharmacies billed $300,663 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,125) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

1,387 generic and 738 brand-name prescriptions · $300,663 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Restasis159$100,890$635
Lumigan139$62,885$452
Xiidra37$29,724$803
Combigan41$19,975$487
Cyclosporine47$18,394$391
See all 17 drugs
Every Part D drug this clinician prescribed
Restasis159$100,890$635
Lumigan139$62,885$452
Xiidra37$29,724$803
Combigan41$19,975$487
Cyclosporine47$18,394$391
Rhopressa42$14,331$341
Rocklatan27$10,696$396
Latanoprost643$5,303$8
Azelastine380$4,913$13
Simbrinza13$4,818$371
Dorzolamide-Timolol209$3,217$15
Brimonidine151$2,413$16
Prednisolone Acetate36$1,437$40
Dorzolamide66$1,077$16
Pilocarpine13$701$54
Ketorolac Tromethamine21$413$20
Timolol Maleate12$338$28

Year by year

Part D prescribing by year
20242,1253400% (0)35%$300,663
20232,1013170% (0)34%$305,172
20222,0903090% (0)35%$294,847
20212,0633170% (0)40%$288,226
20202,6913520% (0)None$314,744
20193,1274450% (0)41%$338,291
20183,6534950% (0)40%$343,682
20173,6465480% (0)None$330,151
20162,8765210% (0)43%$223,964
20154,3177820% (0)44%$309,497
20143,312522None54%$246,038
20133,276553None58%$221,677

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Restasis107$89,162$833
Lumigan202$81,455$403
Combigan38$27,050$712
Cyclosporine26$17,844$686
Rhopressa40$15,883$397
Xiidra13$11,016$847
Latanoprost730$9,617$13
Azelastine307$7,573$25
Rocklatan13$5,325$410
Dorzolamide-Timolol183$4,905$27
Travatan Z12$4,020$335
Brimonidine174$3,592$21
Dorzolamide91$1,979$22
Pilocarpine16$1,230$77
Prednisolone Acetate25$892$36
Olopatadine12$332$28
Ketorolac Tromethamine16$269$17

2022: 20 drugs

Part D drugs prescribed in 2022
Restasis124$97,328$785
Lumigan175$64,070$366
Combigan48$22,848$476
Rhopressa45$13,953$310
Cyclosporine19$11,959$629
Alphagan P25$11,954$478
Latanoprost697$9,889$14
Xiidra12$7,565$630
Dorzolamide-Timolol192$6,686$35
Azelastine285$6,382$22
Travoprost30$5,231$174
Rocklatan13$4,913$378
Simbrinza12$4,551$379
Brimonidine151$2,707$18
Dorzolamide71$2,021$28
Prednisolone Acetate34$1,696$50
Pilocarpine19$1,283$68
Tobramycin-Dexamethasone11$764$69
Olopatadine25$574$23
Timolol Maleate25$289$12

2021: 17 drugs

Part D drugs prescribed in 2021
Restasis137$100,916$737
Lumigan185$65,221$353
Combigan86$31,215$363
Rhopressa49$16,758$342
Xiidra15$10,313$688
Latanoprost685$8,929$13
Alphagan P26$8,053$310
Dorzolamide-Timolol177$6,958$39
Travoprost26$4,890$188
Azelastine242$4,522$19
Brimonidine175$2,999$17
Tobradex11$2,698$245
Prednisolone Acetate42$2,376$57
Dorzolamide88$2,047$23
Pilocarpine19$1,294$68
Olopatadine14$397$28
Timolol Maleate11$148$13

2020: 22 drugs

Part D drugs prescribed in 2020
Restasis132$83,412$632
Lumigan240$76,194$317
Combigan134$41,681$311
Azopt18$11,067$615
Latanoprost941$10,678$11
Rhopressa37$10,170$275
Pazeo45$9,301$207
Travatan Z28$7,833$280
Dorzolamide-Timolol218$7,314$34
Simbrinza25$7,116$285
Alphagan P26$6,914$266
Rocklatan20$5,568$278
Travoprost32$5,321$166
Brimonidine205$4,828$24
Azelastine213$3,798$18
Prednisolone Acetate47$2,875$61
Dorzolamide131$2,855$22
Durezol12$2,490$208
Olopatadine43$2,306$54
Ketorolac Tromethamine13$297$23
Bacitracin-Polymyxin21$287$14
Timolol Maleate25$233$9

2019: 22 drugs

Part D drugs prescribed in 2019
Lumigan266$72,328$272
Restasis115$68,094$592
Combigan177$49,841$282
Travatan Z97$22,017$227
Rhopressa57$14,919$262
Alphagan P51$13,798$271
Azopt28$13,514$483
Latanoprost1,096$12,954$12
Dorzolamide-Timolol281$8,809$31
Methazolamide17$8,665$510
Brimonidine259$8,146$31
Pazeo41$7,939$194
Azelastine229$5,162$23
Simbrinza16$4,392$275
Olopatadine31$3,688$119
Tobradex12$2,889$241
Dorzolamide118$2,667$23
Prednisolone Acetate56$2,649$47
Durezol13$2,538$195
Pilocarpine17$1,938$114
Timolol Maleate56$618$11
Ketorolac Tromethamine15$435$29

2018: 22 drugs

Part D drugs prescribed in 2018
Lumigan275$74,103$269
Restasis135$71,602$530
Combigan225$54,352$242
Alphagan P78$23,586$302
Travatan Z101$21,457$212
Latanoprost1,317$14,265$11
Brimonidine379$12,336$33
Restasis Multidose17$9,401$553
Azopt31$9,289$300
Dorzolamide-Timolol311$6,877$22
Olopatadine66$5,769$87
Prednisolone Acetate97$5,534$57
Azelastine201$5,188$26
Simbrinza22$5,103$232
Pazeo26$4,655$179
Dorzolamide153$3,122$20
Methazolamide13$2,943$226
Pilocarpine35$2,853$82
Durezol15$2,592$173
Acetazolamide14$1,974$141
Timolol Maleate67$1,659$25
Ketorolac Tromethamine29$969$33

2017: 20 drugs

Part D drugs prescribed in 2017
Restasis165$80,221$486
Lumigan289$67,236$233
Combigan191$38,514$202
Alphagan P131$31,474$240
Travatan Z125$25,159$201
Latanoprost1,240$12,976$10
Azopt48$12,667$264
Brimonidine340$9,684$28
Azelastine205$8,054$39
Dorzolamide-Timolol373$7,691$21
Prednisolone Acetate90$5,402$60
Pataday24$4,504$188
Olopatadine34$3,353$99
Simbrinza16$2,964$185
Acetazolamide20$2,911$146
Pilocarpine39$2,876$74
Dorzolamide127$2,299$18
Timolol Maleate70$1,526$22
Ketorolac Tromethamine40$1,335$33
Atropine Sulfate12$428$36

2016: 18 drugs

Part D drugs prescribed in 2016
Lumigan259$49,679$192
Restasis92$40,205$437
Alphagan P121$23,755$196
Combigan151$22,763$151
Prednisolone Acetate199$13,732$69
Travatan Z64$13,083$204
Azopt35$11,116$318
Pataday66$10,972$166
Latanoprost962$10,491$11
Azelastine152$6,787$45
Dorzolamide-Timolol295$5,625$19
Brimonidine197$4,705$24
Simbrinza13$2,211$170
Olopatadine13$1,346$104
Dorzolamide67$1,237$18
Ketorolac Tromethamine56$1,161$21
Timolol Maleate47$368$8
Ofloxacin17$269$16

2015: 22 drugs

Part D drugs prescribed in 2015
Lumigan309$55,140$178
Prednisolone Acetate602$52,180$87
Restasis85$33,129$390
Combigan187$25,056$134
Alphagan P161$23,659$147
Patanol89$23,003$258
Travatan Z108$18,857$175
Pataday94$15,044$160
Latanoprost917$11,591$13
Ketorolac Tromethamine551$9,075$16
Azopt39$8,615$221
Azelastine129$6,744$52
Ofloxacin368$6,331$17
Dorzolamide-Timolol262$6,071$23
Brimonidine164$4,332$26
Pilocarpine35$3,271$93
Methazolamide14$2,341$167
Dorzolamide68$1,471$22
Bacitracin13$850$65
Timolol Maleate70$464$7
Neomycin-Polymyxin-Dexameth18$332$18
Cromolyn11$78$7

2014: 21 drugs

Part D drugs prescribed in 2014
Lumigan486$65,121$134
Combigan218$25,234$116
Restasis74$22,788$308
Travatan Z138$19,297$140
Alphagan P157$19,002$121
Prednisolone Acetate269$18,274$68
Latanoprost894$15,432$17
Patanol63$10,625$169
Dorzolamide-Timolol297$9,865$33
Azopt60$9,311$155
Pataday64$9,227$144
Azelastine103$6,363$62
Brimonidine138$4,170$30
Methazolamide16$2,591$162
Dorzolamide64$1,628$25
Acetazolamide11$955$87
Timolol Maleate104$877$8
Pilocarpine11$830$75
Epinastine12$747$62
Flurbiprofen68$475$7
Ketorolac Tromethamine14$424$30

2013: 21 drugs

Part D drugs prescribed in 2013
Lumigan526$61,379$117
Restasis105$27,921$266
Combigan208$21,488$103
Travatan Z152$18,680$123
Alphagan P143$15,775$110
Latanoprost722$15,563$22
Dorzolamide-Timolol244$9,334$38
Pataday66$8,604$130
Prednisolone Acetate384$8,164$21
Azopt58$7,736$133
Azelastine98$7,226$74
Ketorolac Tromethamine145$3,496$24
Brimonidine68$2,522$37
Epinastine31$2,491$80
Dorzolamide35$1,069$31
Timolol Maleate80$922$12
Ofloxacin92$829$9
Bacitracin14$801$57
Pilocarpine12$734$61
Cromolyn19$406$21
Flurbiprofen16$123$8

Money from drug and device companies

$305 in 2025

Industry payments by year
202513None$305
202411None$125
202311None$87
202222None$219
202134$325$511
202023$250$344
2019638$12,210$22,591

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Alcon VisionTryptyr$305
3 payments
  • Meals for Clareon · 2025-10-18 · $75
  • Meals for Tryptyr · 2025-10-14 · $125
  • Meals for Clareon Panoptix Pro · 2025-07-16 · $105
See all 3 published payments
Every published payment
Alcon VisionMeals · 2025-10-18Clareon$75
Alcon VisionMeals · 2025-10-14Tryptyr$125
Alcon VisionMeals · 2025-07-16Clareon Panoptix Pro$105
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $125

Payments by company in 2024
Alcon VisionRocklatan$125
1 payment
  • Meals for Rocklatan · 2024-07-16 · $125

2023: $87

Payments by company in 2023
Alcon VisionRocklatan$87
1 payment
  • Meals for Rocklatan · 2023-03-20 · $87

2022: $219

Payments by company in 2022
AbbvieDurysta$123
1 payment
  • Meals for Durysta · 2022-06-28 · $123
Alcon VisionRhopressa$95
1 payment
  • Meals for Rhopressa · 2022-08-02 · $95

2021: $511

Payments by company in 2021
AllerganDurysta$328
2 payments
  • Meals for Restasis Multidose · 2021-08-13 · $3
  • Consulting for Durysta · 2021-04-01 · $325
Aerie PharmaceuticalsRhopressa$162
1 payment
  • Meals for Rhopressa · 2021-07-21 · $162
Sun Pharmaceutical IndustriesCequa$20
1 payment
  • Meals for Cequa · 2021-12-15 · $20

2020: $344

Payments by company in 2020
AllerganDurysta$270
2 payments
  • Consulting · 2020-12-10 · $250
  • Meals for Durysta · 2020-10-07 · $20
Aerie PharmaceuticalsRhopressa$74
1 payment
  • Meals for Rhopressa · 2020-01-30 · $74

2019: $22,591

Payments by company in 2019
AllerganLumigan$19,885
25 payments
  • Travel · 2019-12-06 · $159
  • Travel · 2019-12-06 · $218
  • Consulting · 2019-12-06 · $3,250
  • Meals · 2019-12-06 · $215
  • Meals · 2019-12-06 · $38
  • Meals · 2019-12-06 · $50
  • Meals · 2019-10-12 · $108
  • Meals · 2019-10-03 · $104
  • Meals for Restasis · 2019-10-01 · $125
  • Travel · 2019-09-20 · $502
  • Meals · 2019-09-20 · $65
  • Meals · 2019-09-20 · $38
  • Meals · 2019-09-20 · $2
  • Meals · 2019-09-20 · $9
  • Travel · 2019-09-20 · $2,933
  • Travel · 2019-09-20 · $4,220
  • Consulting · 2019-09-20 · $7,000
  • Travel · 2019-09-20 · $17
  • Travel · 2019-09-20 · $78
  • Travel · 2019-09-20 · $411
  • Travel · 2019-09-20 · $53
  • Meals · 2019-09-19 · $39
  • Meals for Lumigan · 2019-09-11 · $124
  • Meals for Lumigan · 2019-08-15 · $7
  • Meals · 2019-05-04 · $118
Alcon VisionNgenuity$2,192
5 payments
  • Meals · 2019-11-09 · $26
  • Consulting for Ngenuity · 2019-11-08 · $1,960
  • Meals · 2019-10-11 · $141
  • Meals · 2019-05-03 · $8
  • Meals for Centurion · 2019-01-23 · $57
Aerie PharmaceuticalsRhopressa$208
2 payments
  • Meals for Rhopressa · 2019-06-11 · $120
  • Meals for Rhopressa · 2019-05-07 · $88
Sight SciencesOmni$128
3 payments
  • Meals for Omni · 2019-11-17 · $103
  • Meals for Omni · 2019-08-07 · $11
  • Meals for Omni · 2019-06-13 · $14
Johnson & Johnson Surgical VisionTecnis Multifocal Family of 1-Piece Iols$99
2 payments
  • Meals for Tecnis 1-Piece Iol · 2019-09-12 · $20
  • Meals for Tecnis Multifocal Family of 1-Piece Iols · 2019-03-12 · $79
IvantisHydrus$79
1 payment
  • Meals for Hydrus · 2019-12-13 · $79

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Allergan, Inc. · An Extension Trial To Evaluate the Long-Term Safety and Efficacy of Bimatoprost Sr in Patients With Open Angle Glaucoma Or Ocular Hypertension · 2020Their institution$35,087
Allergan, Inc. · An Extension Trial To Evaluate the Long-Term Safety and Efficacy of Bimatoprost Sr in Patients With Open Angle Glaucoma Or Ocular Hypertension · 2021Their institution$15,755
ABBVIE INC. · Long-Term Safety and Efficacy Extension Trial of Bimatoprost Sr · 2022Their institution$8,654
Allergan, Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020Their institution$7,571
Allergan, Inc. · An Extension Trial To Evaluate the Long-Term Safety and Efficacy of Bimatoprost Sr in Patients With Open Angle Glaucoma Or Ocular Hypertension · 2022Their institution$4,367
ABBVIE INC. · Long-Term Safety and Efficacy Extension Trial of Bimatoprost Sr · 2023Their institution$3,275
Allergan Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019Their institution$2,980

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1760518823
Licence
NY 00246048, NY 249681
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X)
Mailing address
725 E 9th St, Apt. 2f, New York, NY, 10009
NPI first listed
2007-02-25
NPI last updated
2018-05-04

This is when the NPI record was last certified, not a medical board exam.